Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal

References

• SabinCASchwenkAJohnsonMALate diagnosis in the HAART era: proposed common definitions and associations with mortalityAIDS201024572372720057312
   PubMed Web of Science ®Google Scholar
• Abdool KarimSSNaidooKGroblerATiming of initiation of antiretroviral drugs during tuberculosis therapyN Engl J Med2010362869770620181971
   PubMed Web of Science ®Google Scholar
• ZolopaAAndersenJPowderlyWEarly antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trialPLoS One200945e557519440326
   PubMed Web of Science ®Google Scholar
• BlancFXSokTLaureillardDSignificant enhancement in survival with early (2 weeks) vs late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis18th International AIDS Conference (IAC)July 18–23, 2010Vienna, Austria
   Google Scholar
• GrantPMKomarowLAndersenJRisk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs deferred ART during an opportunistic infectionPLoS One201057e1141620617176
   PubMed Web of Science ®Google Scholar
• WhartonJMColemanDLWofsyCBTrimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trialAnn Intern Med1986105137443521428
   PubMed Web of Science ®Google Scholar
• DannemannBMcCutchanJAIsraelskiDTreatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment GroupAnn Intern Med1992116133431727093
   PubMed Web of Science ®Google Scholar
• Helweg-LarsenJTsolakiAGMillerRFLundgrenBWakefieldAEClusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotypingQJM1998911281382010024946
   PubMed Web of Science ®Google Scholar
• KleinNCDuncansonFPLenoxTHTrimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trialAIDS1992633013051567574
   PubMed Web of Science ®Google Scholar
• SafrinSFinkelsteinDMFeinbergJComparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study GroupAnn Intern Med199612497928028610948
   PubMed Web of Science ®Google Scholar
• SattlerFRCowanRNielsenDMRuskinJTrimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover studyAnn Intern Med198810942802873260759
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human ServicesGuidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescentsJune 182008 Available at: http://aidsinfo.nih.gov/Accessed March 3, 2011
   Google Scholar
• BozzetteSASattlerFRChiuJA controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment GroupN Engl J Med199032321145114572233917
   PubMed Web of Science ®Google Scholar
• MontanerJSLawsonLMLevittNBelzbergASchechterMTRuedyJCorticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)Ann Intern Med1990113114202190515
   PubMed Web of Science ®Google Scholar
• Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndromeThe National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis PneumoniaN Engl J Med199032321150015042136587
   PubMed Web of Science ®Google Scholar
• HughesWLeoungGKramerFComparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDSN Engl J Med199332821152115278479489
   PubMed Web of Science ®Google Scholar
• SmegoRAJrNagarSMalobaBPoparaMA meta-analysis of salvage therapy for Pneumocystis carinii pneumoniaArch Intern Med2001161121529153311427101
   PubMedGoogle Scholar
• GilksCFOjooSAOjooJCInvasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, KenyaLancet199634790037187238602001
   PubMed Web of Science ®Google Scholar
• GillCJMwanakasaleVFoxMPImpact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian womenJ Infect Dis200819771000100518419536
   PubMed Web of Science ®Google Scholar
• FalcoVFernandez de SevillaTAlegreJBacterial pneumonia in HIV-infected patients: a prospective study of 68 episodesEur Respir J1994722352398162975
   PubMed Web of Science ®Google Scholar
• LuftBJHafnerRKorzunAHToxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study TeamN Engl J Med19933291499510008366923
   PubMed Web of Science ®Google Scholar
• KatlamaCDe WitSO’DohertyEVan GlabekeMClumeckNPyrimethamine-clindamycin vs pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDSClin Infect Dis19962222682758838183
   PubMed Web of Science ®Google Scholar
• DedicoatMLivesleyNManagement of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)Cochrane database Syst Rev20063CD00542016856096
   PubMedGoogle Scholar
• ChirgwinKHafnerRLeportCRandomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Clin Infect Dis20023491243125011941551
   PubMed Web of Science ®Google Scholar
• BeraudGPierre-FrancoisSFoltzerACotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994–2006Am J Trop Med Hyg200980458358719346380
   PubMed Web of Science ®Google Scholar
• TorreDCasariSSperanzaFRandomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study GroupAntimicrob Agents Chemother1998426134613499624473
   PubMed Web of Science ®Google Scholar
• RiberaEFernandez-SolaAJusteCComparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patientsClin Infect Dis19992961461146610585796
   PubMed Web of Science ®Google Scholar
• GirardPMLandmanRGaudeboutCDapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study GroupN Eng J Med19933282115141520
   PubMed Web of Science ®Google Scholar
• LarsenRABozzetteSAJonesBEFluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDSClin Infect Dis19941947417457803641
   PubMed Web of Science ®Google Scholar
• LarsenRALealMAChanLSFluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trialAnn Intern Med199011331831872197908
   PubMed Web of Science ®Google Scholar
• LarsenRABauerMWeinerJMEffect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitisAntimicrob Agents Chemother1996409217821828878602
   PubMed Web of Science ®Google Scholar
• BatesDWSuLYuDTMortality and costs of acute renal failure associated with amphotericin B therapyClin Infect Dis200132568669311229835
   PubMed Web of Science ®Google Scholar
• LeendersACReissPPortegiesPLiposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitisAIDS19971112146314719342068
   PubMed Web of Science ®Google Scholar
• HamillRJSobelJDEl-SadrWComparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safetyClin Infect Dis201051222523220536366
   PubMed Web of Science ®Google Scholar
• BennettJEDismukesWEDumaRJA comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitisN Engl J Med19793013126131449951
   PubMed Web of Science ®Google Scholar
• Van der HorstCMSaagMSCloudGATreatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials GroupN Engl J Med1997337115219203426
   PubMed Web of Science ®Google Scholar
• NussbaumJCJacksonANamarikaDCombination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiClin Infect Dis201050333834420038244
   PubMed Web of Science ®Google Scholar
• MakadzangeATNdhlovuCETakarindaKEarly versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan AfricaClin Infect Dis201050111532153820415574
   PubMed Web of Science ®Google Scholar
• PerfectJRDismukesWEDromerFClinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of AmericaClin Infect Dis201050329132220047480
   PubMed Web of Science ®Google Scholar
• BozzetteSALarsenRAChiuJA placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment GroupN Engl J Med199132495805841992319
   PubMed Web of Science ®Google Scholar
• PowderlyWGSaagMSCloudGAA controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupN Engl J Med1992326127937981538722
   PubMed Web of Science ®Google Scholar
• SanchezTHBrooksJTSullivanPSBacterial diarrhea in persons with HIV infection, United States, 1992–2002Clin Infect Dis200541111621162716267735
   PubMed Web of Science ®Google Scholar
• AnguloFJSwerdlowDLBacterial enteric infections in persons infected with human immunodeficiency virusClin Infect Dis199521Suppl 1S84S938547518
   PubMed Web of Science ®Google Scholar
• JacobsJLGoldJWMurrayHWRobertsRBArmstrongDSalmonella infections in patients with the acquired immunodeficiency syndromeAnn Intern Med198510221861883881072
   PubMed Web of Science ®Google Scholar
• TocalliLNardiGMamminoASalvaggioASalvaggioLSalmonellosis diagnosed by the laboratory of the ‘L. Sacco’ Hospital of Milan (Italy) in patients with HIV diseaseEur J Epidemiol1991766906951783064
   PubMed Web of Science ®Google Scholar
• GilksCFBrindleRJOtienoLSLife-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, KenyaLancet199033687145455491975046
   PubMed Web of Science ®Google Scholar
• MolinaJCasinIHausfaterPCampylobacter infections in HIV-infected patients: clinical and bacteriological featuresAIDS1995988818857576322
   PubMed Web of Science ®Google Scholar
• HungCCHungMNHsuehPRRisk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistanceClin Infect Dis2007455e60e6717682981
   PubMed Web of Science ®Google Scholar
• GuerrantRLVan GilderTSteinerTSPractice guidelines for the management of infectious diarrheaClin Infect Dis200132333135111170940
   PubMed Web of Science ®Google Scholar
• GordonMABandaHTGondweMNon-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescenceAIDS200216121633164112172085
   PubMed Web of Science ®Google Scholar
• CelumCLChaissonRERutherfordGWBarnhartJLEchenbergDFIncidence of salmonellosis in patients with AIDSJ Infect Dis1987156699810023680999
   PubMed Web of Science ®Google Scholar
• HungCCHsiehSMHsiaoCFChenMYShengWHRisk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapyAIDS200115564564711317004
   PubMed Web of Science ®Google Scholar
• TribbleDRSandersJWPangLWTraveler’s diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimenClin Infect Dis200744333834617205438
   PubMed Web of Science ®Google Scholar
• ChristopherPRDavidKVJohnSMSankarapandianVAntibiotic therapy for Shigella dysenteryCochrane Database Syst Rev20108CD00678420687081
   PubMed Web of Science ®Google Scholar
• LuSSSchwartzJMSimonDMBrandtLJClostridium difficileassociated diarrhea in patients with HIV positivity and AIDS: a prospective controlled studyAm J Gastroenterol1994898122612298053439
   PubMed Web of Science ®Google Scholar
• ConlonCPPinchingAJPereraCUMoodyALuoNPLucasSBHIV-related enteropathy in Zambia: a clinical, microbiological, and histological studyAm J Trop Med Hyg199042183882301710
   PubMed Web of Science ®Google Scholar
• CarrAMarriottDFieldAVasakECooperDATreatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapyLancet199835190982562619457096
   PubMed Web of Science ®Google Scholar
• MiaoYMAwad-El-KariemFMFranzenCEradication of cryptosporidia and microsporidia following successful antiretroviral therapyJ Acquir Immune Defic Syndr200025212412911103042
   PubMed Web of Science ®Google Scholar
• CabadaMMWhiteACJrTreatment of cryptosporidiosis: do we know what we think we know?Curr Opin Infect Dis201023549449920689422
   PubMed Web of Science ®Google Scholar
• TziporiSRandWGriffithsJWidmerGCrabbJEvaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulinClin Diagn Lab Immunol1994144504638556484
   PubMedGoogle Scholar
• HewittRGYiannoutsosCTHiggsESParomomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial GroupClin Infect Dis20003141084109211049793
   PubMed Web of Science ®Google Scholar
• WhiteACJrChappellCLHayatCSKimballKTFlaniganTPGoodgameRWParomomycin for cryptosporidiosis in AIDS: a prospective, double-blind trialJ Infect Dis199417024194248035029
   PubMed Web of Science ®Google Scholar
• AbubakarIAliyuSHArumugamCUsmanNKHunterPRTreatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysisBr J Clin Pharmacol200763438739317335543
   PubMed Web of Science ®Google Scholar
• SmithNHCronSValdezLMChappellCLWhiteACJrCombination drug therapy for cryptosporidiosis in AIDSJ Infect Dis199817839009039728569
   PubMed Web of Science ®Google Scholar
• RossignolJFHidalgoHFeregrinoMA double-‘blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in MexicoTrans R Soc Trop Med Hyg199892666366610326116
   PubMed Web of Science ®Google Scholar
• MolinaJMTourneurMSarfatiCFumagillin treatment of intestinal microsporidiosisN Engl J Med2002346251963196912075057
   PubMed Web of Science ®Google Scholar
• MolinaJMChastangCGoguelJAlbendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trialJ Infect Dis19981775137313779593027
   PubMed Web of Science ®Google Scholar
• DieterichDTLewEAKotlerDPPolesMAOrensteinJMTreatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDSJ Infect Dis199416911781838277179
   PubMed Web of Science ®Google Scholar
• KleinRSHarrisCASmallCBMollBLesserMFriedlandGHOral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndromeN Engl J Med198431163543586738653
   PubMed Web of Science ®Google Scholar
• PonsVGreenspanDDebruinMTherapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study GroupJ Acquir Immune Defic Syndr1993612131113168254467
   PubMed Web of Science ®Google Scholar
• De WitSWeertsDGoossensHClumeckNComparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDSLancet1989186417467482564563
   PubMed Web of Science ®Google Scholar
• SmithDEMidgleyJAllanMConnollyGMGazzardBGItraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIVAIDS1991511136713711662959
   PubMed Web of Science ®Google Scholar
• MeunierFAounMGerardMTherapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs ketoconazoleRev Infect Dis199012Suppl 3S364S3682184513
   PubMedGoogle Scholar
• GraybillJRVazquezJDarouicheRORandomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patientsAm J Med1998104133399528717
   PubMed Web of Science ®Google Scholar
• CartledgeJDMidgelyJGazzardBGItraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosisJ Clin Pathol19975064774809378812
   PubMed Web of Science ®Google Scholar
• BarbaroGBarbariniGCalderonWGrisorioBAlciniPDi LorenzoGFluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida EsophagitisGastroenterology19961115116911778898629
   PubMed Web of Science ®Google Scholar
• MetcalfSCDockrellDHImproved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hostsJ Infect200755428729917697716
   PubMed Web of Science ®Google Scholar
• VillanuevaAGotuzzoEArathoonEGA randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasisAm J Med2002113429429912361815
   PubMed Web of Science ®Google Scholar
• KrauseDSSimjeeAEvan RensburgCA randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasisClin Infect Dis200439677077515472806
   PubMed Web of Science ®Google Scholar
• De WetNLlanos-CuentasASuleimanJA randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patientsClin Infect Dis200439684284915472817
   PubMed Web of Science ®Google Scholar
• KartsonisNDiNubileMJBartizalKHicksPSRyanDSableCAEfficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazoleJ Acquir Immune Defic Syndr200231218318712394797
   PubMed Web of Science ®Google Scholar
• SkiestDJVazquezJAAnsteadGMPosaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infectionClin Infect Dis200744460761417243069
   PubMed Web of Science ®Google Scholar
• PerfectJRMarrKAWalshTJVoriconazole treatment for less-common, emerging, or refractory fungal infectionsClin Infect Dis20033691122113112715306
   PubMed Web of Science ®Google Scholar
• WilcoxCMAlexanderLNClarkWSThompsonSE3rdFluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptomsGastroenterology19961106180318098964406
   PubMed Web of Science ®Google Scholar
• DunneMFesselJKumarPA randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virusClin Infect Dis20003151245125211073759
   PubMed Web of Science ®Google Scholar
• WardTTRimlandDKauffmanCHuyckeMEvansTGHeifetsLRandomized, open-label trial of azithromycin plus ethambutol vs clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research ConsortiumClin Infect Dis1998275127812859827282
   PubMed Web of Science ®Google Scholar
• KoletarSLBerryAJCynamonMHAzithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patientsAntimicrob Agents Chemother199943122869287210582873
   PubMed Web of Science ®Google Scholar
• ChaissonREBensonCADubeMPClarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamAnn Intern Med1994121129059117978715
   PubMed Web of Science ®Google Scholar
• BensonCAWilliamsPLCurrierJSA prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndromeClin Infect Dis20033791234124314557969
   PubMed Web of Science ®Google Scholar
• GordinFMSullamPMShafranSDA randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complexClin Infect Dis19992851080108510452638
   PubMed Web of Science ®Google Scholar
• ChaissonREKeiserPPierceMClarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infectionAIDS19971133113179147422
   PubMed Web of Science ®Google Scholar
• ShafranSDSingerJZarownyDPA comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupN Engl J Med199633563773838676931
   PubMed Web of Science ®Google Scholar
• HeifetsLMorNVanderkolkJMycobacterium avium strains resistant to clarithromycin and azithromycinAntimicrob Agents Chemother19933711236423708031351
   PubMed Web of Science ®Google Scholar
• DubeMPTorrianiFJSeeDSuccessful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment GroupClin Infect Dis199928113613810028084
   PubMed Web of Science ®Google Scholar
• WormserGPHorowitzHDworkinBLow-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patientsAntimicrob Agents Chemother1994389221522177811052
   PubMed Web of Science ®Google Scholar
• KemperCABermudezLEDeresinskiSCImmunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factorJ Infect Dis199817749149209534963
   PubMed Web of Science ®Google Scholar
• KedzierskaKPaukovicsGHandleyAInterferon-gamma therapy activates human monocytes for enhanced phagocytosis of Mycobacterium avium complex in HIV-infected individualsHIV Clin Trials200452808515116283
   PubMed Web of Science ®Google Scholar
• LauwFNvan Der MeerJTde MetzJDannerSAvan Der PollTNo beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infectionClin Infect Dis2001324e81e8211181141
   PubMed Web of Science ®Google Scholar
• Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials GroupOphthalmology19941017125012618035989
   PubMed Web of Science ®Google Scholar
• The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis TrialAm J Ophthalmol2001131445746711292409
   PubMed Web of Science ®Google Scholar
• MartinDFSierra-MaderoJWalmsleySA controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitisN Engl J Med2002346151119112611948271
   PubMed Web of Science ®Google Scholar
• MuschDCMartinDFGordonJFDavisMDKuppermannBDTreatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study GroupN Engl J Med1997337283909211677
   PubMed Web of Science ®Google Scholar
• TognonMSTurriniBMasieroGIntravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitisEur J Ophthalmol1996621791828823593
   PubMedGoogle Scholar
• CochereauIBelayachiNDiraisonCTreatment of CMV retinitis with intravitreal foscarnetJ Fr Ophthalmol19982110723726
   Web of Science ®Google Scholar
• VelezGRoyCEWhitcupSMChanCCRobinsonMRHigh-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitisAm J Ophthalmol2001131339639711239885
   PubMed Web of Science ®Google Scholar
• KuppermannBDQuicenoJIFlores-AguilarMIntravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapyJ Infect Dis19931686150615098245536
   PubMed Web of Science ®Google Scholar
• ArevaloJFGonzalezCCapparelliEVIntravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitisJ Infect Dis199517249519567561215
   PubMed Web of Science ®Google Scholar
• MarxJLKapustaMAPatelSSUse of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitisArch Ophthalmol199611478158208660164
   PubMedGoogle Scholar
• HattonMPDukerJSReichelEMorleyMGPuliafitoCATreatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implantRetina199818150559502281
   PubMed Web of Science ®Google Scholar
• Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment TrialThe Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials GroupArch Ophthalmol1996114123338540847
   PubMedGoogle Scholar
• JabsDAEngerCDunnJPFormanMCytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study GroupJ Infect Dis199817737707739498461
   PubMed Web of Science ®Google Scholar
• JabsDAMartinBKFormanMSLongitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8Am J Ophthalmol2001132570071011704031
   PubMed Web of Science ®Google Scholar
• JabsDAEngerCFormanMDunnJPIncidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study GroupAntimicrob Agents Chemother1998429224022449736542
   PubMed Web of Science ®Google Scholar
• Anduze-FarisBMFilletAMGozlanJInduction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patientsAIDS200014551752410780714
   PubMed Web of Science ®Google Scholar
• EdwardsSGGroverDScottCCytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utilityInt J STD AIDS200718532132317524192
   PubMed Web of Science ®Google Scholar
• DieterichDTRahminMCytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literatureJ Acquir Immune Defic Syndr19914Suppl 1S29S351848619
   PubMed Web of Science ®Google Scholar